学术探索
学术期刊
新闻热点
数据分析
智能评审

Predictive cancer genomics - what do we need?

被引：17
作者：
Brenton, JD [1 ]
Caldas, C [1 ]
机构：
[1] Univ Cambridge, Dept Oncol, Canc Genom Program, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England
来源：
LANCET | 2003年 / 362卷 / 9381期
关键词：
D O I：
10.1016/S0140-6736(03)14053-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 10 条
  • [1] A guide to microarray experiments - an open letter to the scientific journals
    Ball, CA
    Sherlock, G
    Parkinson, H
    Rocca-Sera, P
    Brooksbank, C
    Causton, HC
    Cavalieri, D
    Gaasterland, T
    Hingamp, P
    Holstege, F
    Ringwald, M
    Spellman, P
    Stoeckert, CJ
    Stewart, JE
    Taylor, R
    Brazma, A
    Quackenbush, J
    [J]. LANCET, 2002, 360 (9338) : 1019 - 1019
  • [2] PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE
    BONADONNA, G
    VERONESI, U
    BRAMBILLA, C
    FERRARI, L
    LUINI, A
    GRECO, M
    BARTOLI, C
    DEYOLDI, GC
    ZUCALI, R
    RILKE, F
    ANDREOLA, S
    SILVESTRINI, R
    DIFRONZO, G
    VALAGUSSA, P
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) : 1539 - 1545
  • [3] Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
    Chollet, P
    Amat, S
    Cure, H
    de Latour, M
    Le Bouedec, G
    Mouret-Reynier, MA
    Ferriere, JP
    Achard, JL
    Dauplat, J
    Penault-Llorca, F
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (07) : 1041 - 1046
  • [4] Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma
    Cocquyt, VF
    Blondeel, PN
    Depypere, HT
    Praet, MM
    Schelfhout, VR
    Silva, OE
    Hurley, J
    Serreyn, RF
    Daems, KK
    Van Belle, SJP
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (04): : 361 - 367
  • [5] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
    Faneyte, IF
    Schrama, JG
    Peterse, JL
    Remijnse, PL
    Rodenhuis, S
    van der Vijver, MJ
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (03) : 406 - 412
  • [6] Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
    Kuerer, HM
    Newman, LA
    Smith, TL
    Ames, FC
    Hunt, KK
    Dhingra, K
    Theriault, RL
    Singh, G
    Binkley, SM
    Sneige, N
    Buchholz, TA
    Ross, MI
    McNeese, MD
    Buzdar, AU
    Hortobagyi, GN
    Singletary, SE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 460 - 469
  • [7] *NAT CANC I, CACORE NCICB CANC IN
  • [8] *NCBI, GEN EXP OMN
  • [9] Medical applications of microarray technologies: a regulatory science perspective
    Petricoin, EF
    Hackett, JL
    Lesko, LJ
    Puri, RK
    Gutman, SI
    Chumakov, K
    Woodcock, J
    Feigal, DW
    Zoon, KC
    Sistare, FD
    [J]. NATURE GENETICS, 2002, 32 (Suppl 4) : 474 - 479
  • [10] PRIMARY MEDICAL (NEOADJUVANT) CHEMOTHERAPY FOR OPERABLE BREAST-CANCER
    SMITH, IE
    JONES, AL
    OBRIEN, MER
    MCKINNA, JA
    SACKS, N
    BAUM, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1796 - 1799
1